You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-metastatic castration-resistant prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Prostate Cancer Trial in Japan (Enzalutamide)

Completed
  • Prostate Cancer
  • Kita-gun, Kagawa-prefecture, Japan
  • +3 more
May 24, 2022

Prostate Cancer Trial in Multiple Locations (Darolutamide 600 mg twice daily, Placebo 600 mg twice daily, Androgen deprivation

Recruiting
  • Prostate Cancer
  • Darolutamide 600 mg twice daily
  • +2 more
  • Multiple Locations, China
    Many Locations
Aug 2, 2022

Non-metastatic Castration-resistant Prostate Cancer Trial in India (Darolutamide (Nubeqa, BAY1841788))

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • Hyderabad, Andhra Pradesh, India
  • +22 more
Jul 29, 2022

Prostatic Tumors Trial in Brazil, Colombia, Mexico (Apalutamide, ADT (Standard of Care))

Available
  • Prostatic Neoplasms
  • Florianopolis, Brazil
  • +19 more
Aug 2, 2022

Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))

Recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +29 more
Aug 15, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Salt Lake

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Atezolizumab
  • Cabozantinib S-malate
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Mar 11, 2022

Castration-Resistant Prostate Cancer Trial in Las Vegas, Port Jefferson Station (Enzalutamide or Abiraterone or Apalutamid)

Recruiting
  • Castration-Resistant Prostate Cancer
  • Enzalutamide or Abiraterone or Apalutamid
  • Las Vegas, Nevada
  • +1 more
Apr 4, 2022

Castration Resistant Prostatic Cancer Trial in Australia (Docetaxel intermittent, Docetaxel standard of care)

Recruiting
  • Castration Resistant Prostatic Cancer
  • Docetaxel intermittent
  • Docetaxel standard of care
  • Albury, New South Wales, Australia
  • +4 more
Feb 14, 2022

Metastatic Prostate Cancer, Pain Trial in New York, Chapel Hill (Radium-223)

Completed
  • Metastatic Prostate Cancer
  • Pain
  • New York, New York
  • +2 more
Feb 3, 2022

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Withdrawn
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

Not yet recruiting
  • Prostate Cancer
  • Beijing, Beijign, China
  • +1 more
Jul 25, 2023

Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

Recruiting
  • Prostate Cancer
  • Prostate Cancer Metastatic
  • La Jolla, California
  • +1 more
Feb 2, 2023

Non-study Population of Symptomatic mCRPC Patients Treated With

Active, not recruiting
  • Prostate Cancer Metastatic
  • Bone Metastases
  • Blood tests
  • Amsterdam, Netherlands
  • +1 more
Apr 20, 2022

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Medicines Called Enzalutamide and Abiraterone in People With

    Not yet recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • New York, New York
      Pfizer Inc
    Jul 21, 2023

    Hormone-refractory Prostate Cancer Trial (AMX-500)

    Not yet recruiting
    • Hormone-refractory Prostate Cancer
    • (no location specified)
    Aug 11, 2023

    Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer
    • +3 more
    • Boston, Massachusetts
    • +21 more
    Jan 10, 2023

    Metastatic Prostate Cancer in Pirkanmaa Hospital District in

    Not yet recruiting
    • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
    • Metastatic Castration Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 17, 2023

    Prostate Cancer Trial in Tampa (Abiraterone Acetate)

    Active, not recruiting
    • Prostate Cancer
    • Abiraterone Acetate
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 3, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

    Not yet recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • (no location specified)
    Oct 23, 2023

    Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Metastatic Cancer
    • (no location specified)
    Aug 12, 2022